MAPK1 and chronic obstructive pulmonary disease: The administration of SMAP therapy to cigarette smoke-induced COPD mice models decreased immune cell infiltration into airways and reduced ERK phosphorylation, CTSS expression and enzyme activity when compared to the control group mice [158].